Point-of-Care Ophthalmic Diagnostic Imaging of Retinopathy of Prematurity — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Point-of-Care Ophthalmic Diagnostic Imaging of Retinopathy of Prematurity — Stella

Recruiting

Back to Retinopathy of Prematurity (ROP) trials

Trial locations(1 site)

United States

Vanderbilt University Medical Center, Nashville, Tennessee

Key details

Sponsor

Vanderbilt University Medical Center

Collaborators

National Institutes of Health (NIH)

Enrollment target

~90 participants

Started

February 2025

Primary completion

February 2029

Age range

24 Weeks – 34 Weeks

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov